Dexlansoprazole

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

58 API Suppliers, 22 USDMF, 7 EU WC, 9 KDMF, 15 NDC API, 36 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

24 Drugs in Development

24 Drugs in Development

INTERMEDIATES

7 Intermediate Suppliers

7 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

53 FDF Dossiers, 9 FDA Orange Book, 10 Europe, 4 Canada, 2 South Africa, 28 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE, DELAYED RELEASE;ORAL - 30MG, CAPSULE, DELAYED RELEASE;ORAL - 60MG

RELATED EXCIPIENT COMPANIES

6 Evonik, 1 Rochem International Inc, 5 SPI Pharma, 8 DKSH, 1 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 3 Kirsch Pharma, 1 ACG Worldwide, 3 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 4 BASF, 14 Corel Pharma Chem, 1 Finar, 8 Gangwal Chemicals, 11 Ideal Cures, 2 Ingredion Pharma Solutions, 9 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 2 Microlex e.U, 1 Nanjing Bold Chemical, 1 Novo Excipients, 2 Pluviaendo, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 9 Roquette, 13 Seppic, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Sigachi Industries, 2 The Dow Chemical Company, 1 Valens Pharmachem, 1 Vasa Pharmachem, 1 Vertellus

EXCIPIENTS BY APPLICATIONS

59 Coating Systems & Additives, 26 Controlled & Modified Release, 18 Fillers, Diluents & Binders, 17 Solubilizers, 14 Thickeners and Stabilizers, 11 Film Formers & Plasticizers, 9 Taste Masking, 9 Parenteral, 7 Co-Processed Excipients, 7 Direct Compression, 7 Emulsifying Agents, 7 Rheology Modifiers, 5 Empty Capsules, 5 Disintegrants & Superdisintegrants, 5 API Stability Enhancers, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents, 4 Coloring Agents, 4 Chewable & Orodispersible Aids, 4 Lubricants & Glidants, 3 Granulation, 3 Topical, 1 Soft Gelatin